Product Program year 2024 Source: CMS Open Payments

TruDi NAV Cable

Device Rhinology Otology Laryngology Neurosurgery

PDI 20705031245867

Open in the dashboard

General payments

$185,219

3,220 payments

Research payments

$0

0 payments

Through program year 2024, $185,219 in general payments and $0 in research payments were reported against TruDi NAV Cable (Rhinology Otology Laryngology Neurosurgery).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $11,521 197
2023 General $80,895 1,270
2022 General $61,862 1,084
2021 General $30,941 669

Breakdown

Who paid General payments · program years 2021–2024
  1. Acclarent, Inc $185,105 3,219 payments
  2. Biosense Webster, Inc. $114 1 payment
Top recipients General payments · program year 2024
  1. Kevin Taheri Otolaryngology · Cedar Park, TX $291 3% · 4 payments
  2. Thuong Trinh Otolaryngology/Facial Plastic Surgery · Saint Cloud, FL $228 2% · 2 payments
  3. Troy Woodard Otolaryngology · Cleveland, OH $186 2% · 2 payments
  4. Arthur Wu Otolaryngology · Los Angeles, CA $178 2% · 2 payments
  5. David Conley Otolaryngology · Chicago, IL $170 1% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Otolaryngology $7,131 63% · 97 practitioners
  2. Physician Assistant $1,138 10% · 14 practitioners
  3. Otolaryngology/Facial Plastic Surgery Otolaryngology $829 7% · 10 practitioners
  4. Neurological Surgery $717 6% · 5 practitioners
  5. Facial Plastic Surgery Otolaryngology $553 5% · 5 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. California $2,122 18% · 18 recipients
  2. Texas $1,310 11% · 12 recipients
  3. Florida $1,088 9% · 17 recipients
  4. Pennsylvania $1,029 9% · 16 recipients
  5. New York $926 8% · 9 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

3,220 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record